All insider buying reported in the week of 09/29/2024.
All Insider buyers of the week.
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-27 | Viridian Therapeutics, Inc.\DE | Beetham Thomas W.
(Chief Operating Officer) |
P | Common Stock | A | 5000 | $23.41 - $23.41 | $117,050 |
| 2024-09-26 | Legacy Education Inc. | Robert D. deRose ...
(AtLeastTenPercentOwner) |
P | Common Stock | A | 27000 | $4.08 - $4.80 | $112,580 |
| 2024-10-02 | Oncocyte Corp | James Andrea S.
(Chief Financial Officer) |
P | Common Stock, no par value | A | 33670 | $2.97 - $2.97 | $99,999 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |